Abstract:Type 2 diabetes (T2D) is a metabolic disease that is attributed to a combination of genetic, lifestyle and environmental factors. There is compelling evidence that oxidative stress plays critical roles in the two key events in the pathogenesis of T2D: insulin resistance and pancreatic β-cell dysfunction. Although cytotoxic, reactive oxygen species (ROS) also function as important intracellular signaling molecules involved in insulin signaling and glucose sensing. Too many antioxidants or persistent induction of endogenous antioxidants may result in dampened signal transduction that controls insulin secretion and action. Under oxidative stress, cellular ROS-scavenging capacity may be adaptively upregulated, mostly through activation of the nuclear factor E2-related factor 2 (Nrf2) and transcriptional induction of antioxidant enzymes. It is likely that the oxidative stress-induced antioxidant enzymes, meant to maintain intracellular redox homeostasis and limit oxidative damage, also have a potential to impede ROS that function as physiological signaling molecules. Thus, Nrf2-mediated antioxidant defense seems to play paradoxical Yin- and Yang-roles in regulating glucose homeostasis: while it protects insulin-responsive cells and β-cells from oxidative damage, it also blunts insulin- and glucose-triggered ROS signaling, resulting in insulin resistance and reduced insulin secretion. In contrast, oxidative stress has also been implicated in the pathogenesis of diabetic complications. Antioxidant therapies, either by ROS-neutralizing agents or Nrf2 inducers, display beneficial effects in treating various complications. Considering the cross-regulations among ROS, antioxidants and Nrf2 and their paradoxical roles under various diabetic conditions, site-, time- and species-specific ROS modulation strategies and approaches would be necessary to combat T2D and its complications.

Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2

Transcription Factor Nrf2-Mediated Antioxidant Defense System in the Development of Diabetic Retinopathy

Cross Talks Between Oxidative Stress, Inflammation and Epigenetics in Diabetic Retinopathy

Epigenetic Modifications of Keap1 Regulate Its Interaction with the Protective Factor Nrf2 in the Development of Diabetic Retinopathy

Nutrigenetic reprogramming of oxidative stress

The stress response protein REDD1 promotes diabetes-induced oxidative stress in the retina by Keap1-independent Nrf2 degradation

Epigenetic Modifications of Nrf2-mediated Glutamate–cysteine Ligase: Implications for the Development of Diabetic Retinopathy and the Metabolic Memory Phenomenon Associated with Its Continued Progression

The role of Keap1-Nrf2 signaling pathway during the progress and therapy of diabetic retinopathy

Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives

Redox Regulation of Immunometabolism in Microglia Underpinning Diabetic Retinopathy

Redoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy

The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus

Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy.

NRF2: A potential target for the treatment of diabetic nephropathy

Protective Role of NRF2 in Macrovascular Complications of Diabetes

The Nrf2 Signaling in Retinal Ganglion Cells under Oxidative Stress in Ocular Neurodegenerative Diseases

Oxidative Stress and Its Regulation in Diabetic Retinopathy

The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy

Nrf2 in Type 2 Diabetes and Diabetic Complications: Yin and Yang

Keap1/Nrf2/ARE Signaling Unfolds Therapeutic Targets for Redox Imbalanced-Mediated Diseases and Diabetic Nephropathy